Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Sangivamycin is an effective inhibitor of protein kinase C (PKC, Ki = 10 μM). Sangivamycin exhibits antiproliferative activity against a variety of human cancers.
Description | Sangivamycin is an effective inhibitor of protein kinase C (PKC, Ki = 10 μM). Sangivamycin exhibits antiproliferative activity against a variety of human cancers. |
Targets&IC50 | PKC:10 μM(Ki) |
In vitro | Sangivamycin (0.3 μM; 0-72 hours) exhibits almost maximal cytocidal for MCF7/ADR or cytostatic for MCF7/WT effects. Sangivamycin activates caspases in MCF7/ADR cells. Upon exposure of MCF7/ADR cells to Sangivamycin (0.3 μM), a vast amount of cleavage of lamin A to a 28-kDa fragment is detected within 48 hours. Sangivamycin has differential antitumor effects in drug-sensitive MCF7/wild type (WT) cells, causing growth arrest, and in multidrug-resistant MCF7/adriamycin-resistant (ADR) human breast carcinoma cells, causing massive apoptotic cell death[2]. |
Synonyms | cells, Nucleoside Antimetabolite/Analog, Sangivamycin, antitumor, NSC-65346, PKC, MCF7, NSC65346, BA 90912, Inhibitor, Protein kinase C, NSC 65346, nucleoside, inhibit, analog, BA90912, BA-90912, antiproliferative |
Molecular Weight | 309.28 |
Formula | C12H15N5O5 |
CAS No. | 18417-89-5 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 95 mg/mL (307.17 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.